Từ điển y khoa

Thuật ngữ y khoa chuẩn hóa theo MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5871113,7-bis(2-hydroxyphenyl)-5-phenyl-1,2-diazacyclohepta-1(7),2-dieneMeSH

  structure in first source

• C5723343,7-bis-O-pivaloxymethylquercetinMeSH

  a cytostatic agent; structure in first source

• C5790503,7-dihydro-3-methyl-7-((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-6 H-purin-6-oneMeSH

  from the South China Sea gorgonian Euplexaura robusta; structure in first source

• C5790513,7-dihydro-3-methyl-7-((2E,6E,10Z)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl)-6H-purin-6-oneMeSH

  from the South China Sea gorgonian Euplexaura robusta; structure in first source

• C5843403,7-dimethyl-2,6-octadien-1,6-olideMeSH

  isolated from the fruit of Litsea cubeba and the liverwort Plagiochila rutilans; structure in first source

• C5843413,7-dimethyl-7-hydroxy-2-octen-1,6-olideMeSH

  isolated from the fruit of Litsea cubeba and the liverwort Plagiochila rutilans; structure in first source

• C5681343,7-dimethyl-9-ferrocenylnona-2,4,6,8-tetraenoic acidMeSH

  a retinoic acid receptor alpha activator with antineoplastic activity; structure in firt source

• C5843063,7-dioxolanosta-8,24-dien-26-oic acidMeSH

  isolated from the mushroom Ganoderma lucidum

• C5852983,7-triaza-5-phosphabicyclo(3.3.1)nonaneMeSH

  structure in first source

• C5853973,8-dibutyl-6-(piperidin-1-yl)pyrene-1-carbaldehydeMeSH

  structure in first source

• C5765873,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one glucuronideMeSH

  an ellagitannin metabolite; structure in first source

• C5863223,8-dimethyl-5-isopropyl-6-methoxycoumarinMeSH

  isolated from Mansonia gagei; structure in first source

• C5881533,9-epoxy-p-mentha-1,4(8)-dieneMeSH

  structure in first source

• C5688063,9beta-hydroxy-22alpha,23alpha-epoxy-9(10)-seco-solanida-1,3,5(10)-trieneMeSH

  antiophidic (inhibited myotoxicity without inhibiting phospholipase A2 activity of the Bothrops pauloensis venom); from leaves of Solanum campaniforme; structure in first source

• C5831603-((((3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic acidMeSH

  for treatment of type 2 diabetes; structure in first source

• C5827713-(((2-fluorophenyl)amino)methyl)-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thioneMeSH

  structure in first source

• C5692233-(((3-carboxycyclohexyl)amino)carbonyl)-4-(3-(4-(4-phenoxybutoxy)phenyl)propoxy)benzoic acidMeSH

  a cysteinyl leukotriene receptor 2 antagonist; structure in first source

• C5827723-(((4-chlorophenyl)amino)methyl)-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thioneMeSH

  structure in first source

• C5779593-((1-(dimethylamino)propan-2-yl)oxy)-5-((4-methoxy-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-yl)amino)pyrazine-2-carbonitrileMeSH

  a checkpoint kinase 1 inhibitor; structure in first source

• C5747973-((2,4-dichlorobenzyl)thio)-1,6-dimethyl-5,6-dihydro-1H-pyridazino(4,5-e)(1,3,4)thiadiazin-5-oneMeSH

  a T cell death-associated gene 8 agonist

• C5839993-((2-(dipropylamino)-1,2-dipyridin-2-ylethyl)(propyl)amino)propane-1,2-diolMeSH
• C5849303-((2-acetamido-2-deoxy-beta-D-glucopyranosyl)oxy) -16alpha-hydroxyolean-12-en-28-oic acidMeSH

  cytotoxic compound from the roots of Pithecellobium lucidum

• C5756373-((2-fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrileMeSH

  an PET radioligand for metabotropic glutamate receptor 5; structure in first source

• C5756363-((2-fluorothiazol-4-yl)ethynyl)benzonitrileMeSH

  an PET radioligand for metabotropic glutamate receptor 5; structure in first source

• C5756353-((2-iodothiazol)-4-ethynyl)-5-fluorobenzonitrileMeSH

  an SPECT radioligand for metabotropic glutamate receptor 5; structure in first source

• C5602943-((2-morpholinoethylimino)methyl)benzene-1,2-diolMeSH

  structure in first source

• C5699753-((2R,6R,11R)-8-hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl)-N-phenylpropanamideMeSH

  structure in first source

• C5752003-((3,5-dimethylphenylimino)methyl)benzene-1,2-diolMeSH

  structure in first source

• C5874363-((3-((4-(4-morpholinylmethyl)-1H-pyrrol-2-yl)methylene)-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl)-1,3-thiazolidine-2,4-dioneMeSH

  inhibits MET, AXL, and FGFR kinases; structure in first source

• C5689673-((4-((1,2,4)triazolo(1,5-a)pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methylamino)benzonitrileMeSH

  an ALK5 kinase inhibitor with antineoplastic activity; structure in first source

• C5607553-((4-(2-styrylphenoxy)butanoyl)-4-hydroxyprolyl)thiazolidineMeSH

  inhibits prolyl oligopeptidase

• C5699313-((4-(3,4-dichlorobenzyl)piperazin-1-yl)methyl)-1H-indoleMeSH

  has antineoplastic activity; structure in first source

• C5842153-((4-amino-2-methylpyrimidin-1-ium-5-yl)methyl)-4-methyl-1,3-thiazol-3-ium-5-yl hydrogen pyrophosphate dihydrateMeSH

  structure in first source

• C5845603-((4-benzylpiperazino)methyl)-1H-indoleMeSH

  structure in first source

• C5752753-((4-bromophenoxy)methyl)-N-(4-nitro-1H-pyrazol-1-yl)benzamideMeSH

  a pan-PPAR scaffold; structure in first source

• C5764633-((4-chlorophenyl)(1H-imidazol-2-yl)methylene)-5-(1-ethylpiperidin-4-ylamino)indolin-2-oneMeSH

  a receptor tyrosine kinase inhibitor; structure in first source

• C5694993-((5-((1,2,4)triazolo(1,5-a)pyridin-6-yl)-4-(6-methylpyridin-2-yl)thiazol-2-ylamino)methyl)benzonitrileMeSH

  inhibits ALK5 protein

• C5715263-((5-tert-butyl-1H-imidazol-4-yl)methylene)-6-(2,5-difluorobenzylidene)piperazine-2,5-dioneMeSH

  an antimicrotubule agent; structure in first source

• C5860983-((6-((5-benzylidene-3,6-dioxopiperazin-2-ylidene)methyl)pyridin-3-yloxy)methyl)benzoic acidMeSH

  structure in first source

• C5692223-((6-(ethylsulfonyl)-3-pyridinyl)oxy)-5-(2-hydroxy-1-methylethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamideMeSH

  a glucokinase activator; structure in first source

• C5720043-((7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo(e)pyrrolo(1,2-a)(1,4)diazepin-8-yl)oxy)hexyl-1,2-dihydro-1gamma6-naphtho(1,8-cd)isothiazole-1,1-dioneMeSH

  has antineoplastic activity; structure in first source

• C5760353-((adamantan-1-yl)carbonyl)-1-pentylindoleMeSH

  a cannabimimetic; structure in first source

• C5737763-((dodecylthiocarbonyl)methyl)glutarimideMeSH

  structure in first source

• C5704093-((tetrahydrofuran-2-yl)methyl)-2-thioxo-7H-purin-6-oneMeSH

  inhibits myeloperoxidase

• C5851553-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-6-fluorodibenzo(b,d)thiophene 5,5-dioxideMeSH

  a PET radioligand for alpha7 nicotinic acetylcholine receptors; structure in first source

• C5746343-(1-(1-(benzo(d)oxazol-2-yl)-2-methylpropyl)-1H-1,2,3-triazol-4-yl)-N-hydroxyacrylamideMeSH

  a histone deacetylase inhibitor; structure in first source

• C5751613-(1-(3-cyclopropylmethoxy-4-difluoromethoxybenzyl)-1H-pyrazol-3-yl)benzoic acidMeSH

  structure in first source

• C5816463-(1-aminoethylidene)-2H-chromene-2,4(3H)-dioneMeSH

  structure in first source

• C5735563-(1-benzenesulfonyl-1H-indol-5-yl)-N-hydroxyacrylamideMeSH

  structure in first source

• C5777573-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamideMeSH

  has antineoplastic activity; structure in first source